Trade Conquest

Subscribe Now

| SOXS 1.7999 0.55% | TPET 0.9723 131.50% | ONDS 10.9201 8.33% | STAK 0.6451 51.79% | NVDA 183.195 3.39% | TMDE 2.4421 164.81% | TURB 1.1 62.87% | EONR 0.4744 9.81% | XLE 56.535 1.10% | RYDE 0.3792 63.87% | NOK 8.18 5.96% | BHAT 0.0385 -22.22% | BITO 9.58 5.91% | USEG 1.1 2.80% | TQQQ 49.905 0.78% | IBIT 39.39 5.92% | TZA 6.125 -1.69% | PLUG 1.81 1.12% | NVD 7.01 -6.91% | MSTX 2.52 12.00% | TSLS 5.6299 -0.18% | AES 14.265 -17.45% | JDST 1.235 6.47% | BATL 9.41 70.47% | PLTR 146.31 6.65% | NFLX 96.895 0.68% | AAL 12.5999 -3.60% | TSLL 14.73 0.20% | SQQQ 70.298 -0.78% | QQQ 608.95 0.27% | HYG 80.24 -0.59% | ETHA 15.5687 7.22% | MARA 9.625 7.66% | XLF 51.345 -0.17% | SOFI 18.1699 2.31% | INTC 45.17 -0.96% | IWM 262.86 0.55% | CRCG 2.987 24.46% | BANL 0.6149 36.19% | NU 15.145 1.10% | TSLA 402.96 0.11% | TLT 89.385 -1.25% | BMNR 20.855 9.88% | BYND 0.8628 -8.76% | VG 11.235 15.94% | NIO 4.7 -3.49% | RCAT 13.62 16.91% | KOS 2.165 -7.08% | BKLN 20.215 0.02% | PBR 17.055 2.56%

Canaccord Genuity Raises Doximity Price Target To $67, Maintains Hold

Canaccord Genuity raised its price target on Doximity Inc. (NYSE: DOCS) to $67 from $59 while reiterating a Hold rating.

The firm noted that the rapid pace of change in the large language model (LLM) environment is reshaping healthcare technology. While scale and user adoption remain important, analysts said trust among users is critical to long-term success.

Doximity’s position in the early stages of the AI transition could allow it to become one of the winners in the space, according to the firm. However, at current valuation levels, Canaccord maintained its Hold stance despite the raised target.

Published on: September 18, 2025

More news